Considerations to Limit Off-Target Edits in Gene Editing Experiments

Explore strategies to minimize off-target edits in gene editing experiments during this one-hour webinar presented by Kevin Pridham, a Field Applications Scientist at Thermo Fisher Scientific. Learn about best practices for using engineered nucleases like CRISPR-Cas9 to create cell-based disease models, animal models, and cell therapies while addressing concerns about off-target cleavage. Discover considerations for different experimental scenarios and how Thermo Fisher Scientific is optimizing the gene editing workflow. Gain insights from Pridham's extensive background in cancer biology, drug development, and neurobiology. Earn PACE credits by watching the webinar and following the provided instructions. Connect with LabRoots on various social media platforms for more scientific content and updates.

Considerations to Limit Off-Target Edits in your Gene Editing Experiments